Gevo, Inc. — Form 8-K
Filed July 16, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 28/100
What the filing says
Effective August 20, 2026, Todd Werpy, Ph.D. (former Chief Science Officer at Archer-Daniels-Midland Company) joins Gevo's Board of Directors. Werpy brings 30+ years of experience in sustainable technologies, R&D, manufacturing operations, and enterprise transformation, with expertise in biotechnology, catalysis, and commercialization of bio-based technologies. He holds 36 U.S. patents and is a recipient of the American Chemical Society's Green Chemistry Award. No compensation details, share grants, or board composition changes are disclosed.
Why this rating
Board appointment is routine governance; no material financial transaction or operational change disclosed. Value lies in qualified director addition but is modest relative to $306.5M market cap.
See more from July 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.